Among the markers of osteoclastogenesis, serum levels of sRANKL were significantly higher in women with RA before and after 15 months of anti-TNF-α therapy than in healthy subjects (p < 0.001 for both; Figure 3a). Here, TNF is linked to rheumatoid arthritis.